COMPPARE Newsletter: Spring 2021

A Message from Dr. Nancy Mendenhall

As we look forward to the normal resumption of our work, we ask you to join us in an effort to encourage all men to get back to having their prostates checked annually in order to detect cancers early. Read Dr. Mendenhall’s message.

Partner Site Spotlight: The Karmanos Cancer Institute

The Barbara Ann Karmanos Cancer Institute is the only National Cancer Institute (NCI)-designated comprehensive cancer center in the Detroit metro area and one of just 51 centers of its kind in the U.S. – follow the conversation here.

The Benefits of Transperineal Prostate Biopsy

About two million American men undergo conventional transrectal biopsies each year and up to 2,000 of them die from the procedure, mostly from sepsis infections and bleeding complications. Brotherhood of the Balloon, a COMPPARE Partner Organization, looks at the benefits of a new standard of care – learn more about it.

Cancer Connections Discusses COMPPARE

Cancer Connections, a UF Monthly Educational & Networking Meeting, presented “COMPPARE Clinical Trial: Protons vs Photons to Treat Prostate Cancer” this February – view Dr. Mendenhall’s talk online.

A Patient’s Perspective: Bob Watson

Bob is an active advocate for prostate cancer education, awareness, and treatment, and his involvement in the COMMPARE study as a patient stakeholder serves as an example of his dedication. Read Bob’s story.

COMPPARE Study Progress

Want the latest information on COMPPARE? Find out how many patients have enrolled and how many sites are currently enrolling patients on the COMPPARE Study Progress page.

Research reported in this newsletter was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PCS-2017C1-0422). The views, statements, and opinions presented in this newsletter are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its Board of Governors, or Methodology Committee.